diabetics
Poison Lizard-Derived Drug BYETTA, Launched in the UK
Filed in archive Treatment by Gloria Gamat on May 12, 2007
Poison Lizard-Derived Drug BYETTA, Launched in the UK
Approved in the EU in November 2006 and in the US since April 2005 (as an adjunct therapy to metformin and/or a sulfonylurea) for type 2 diabetes - BYETTA - have been launched in the UK for the treatment the following diabetes-related ailments: heart disease, kidney failure and blindness.

BYETTA is said to have been developed from the spit of a poisonous lizard.

Contrary to how other diabetes drugs and insulin work, BYETTA is so unique that it was developed to help the body produce the right amount of insulin at the right time in type 2 diabetes patients. It comes in a pen that has the patient's daily doses of medicine measured.

BYETTA is a product of Amylin Pharmaceuticals and Eli Lilly and is the first in the new class of drugs called incretin mimetics - it mimics the action of the antidiabetic or glucose- lowering actions of naturally occurring human hormones called incretins.

Click here to find out more about BYETTA.

Related Entries:

Permalink: Poison Lizard-Derived Drug BYETTA, Launched in the UK
Tags: incretin  mimetics  BYETTA  type  2  diabetes  drug  byetta  derived+drug 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/68645
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Poison Lizard-Derived Drug BYETTA, Launched in the UK:

  • Currently 7.80/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.80 out of 5 vote(s) cast.
 
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!